Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.69 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.58 |
| ▸ | PAM | P19021 | 2/20 | 0.53 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.51 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.50 |
| ▸ | PPARG | P37231 | 6/20 | 0.50 |
| ▸ | PPARD | Q03181 | 6/20 | 0.50 |
| ▸ | PPARA | Q07869 | 6/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TLR2 | O60603 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.50 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4651569 | 1.00 | CES2 (0.69) | CES2EPHX2PAMPLA2G4BGPR84 | |
| SCHEMBL7249862 | 1.00 | CES2 (0.69) | CES2EPHX2PAMPLA2G4BGPR84 | |
| SCHEMBL8198788 | 1.00 | CES2 (0.69) | CES2EPHX2PAMPLA2G4BGPR84 | |
| SCHEMBL501889 | 1.00 | CES2 (0.69) | CES2EPHX2PAMPLA2G4BGPR84 | |
| SCHEMBL1603697 | 1.00 | CES2 (0.69) | CES2EPHX2PAMPLA2G4BGPR84 | |
| SCHEMBL21611691 | 1.00 | CES2 (0.69) | CES2EPHX2PAMPLA2G4BGPR84 | |
| SCHEMBL7763197 | 1.00 | CES2 (0.69) | CES2EPHX2PAMPLA2G4BGPR84 | |
| SCHEMBL3296171 | 1.00 | CES2 (0.69) | CES2EPHX2PAMPLA2G4BGPR84 | |
| SCHEMBL21611665 | 1.00 | CES2 (0.69) | CES2EPHX2PAMPLA2G4BGPR84 | |
| SCHEMBL7611940 | 1.00 | CES2 (0.69) | CES2EPHX2PAMPLA2G4BGPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260048037-A1 | FATTY ACID ANALOGS AND THEIR USE IN THE TREATMENT OF COGNITIVE IMPAIRMENT, BEHAVIORAL CONDITIONS, AND CHRONIC PAIN | EPITRACKER INC (US) | 2026-02-19 | — | — | US | disclosed |
| US-12440473-B2 | Fatty acid analogs and their use in the treatment of cognitive impairment, behavioral conditions, and chronic pain | Epitracker, Inc. (US) | 2025-10-14 | — | — | US | disclosed |
| US-11951088-B2 | Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome | Epitracker, Inc. (US) | 2024-04-09 | — | — | US | disclosed |
| US-20230399298-A1 | ACID ADDITION SALT OF INDENE DERIVATIVE PRODRUG AND METHOD FOR PREPARING SAME | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2023-12-14 | — | — | US | disclosed |
| US-20230303491-A1 | DONEPEZIL ETHER PALMITATE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2023-09-28 | — | — | US | disclosed |
| EP-4238963-A1 | ACID ADDITION SALT OF INDENE DERIVATIVE PRODRUG AND METHOD FOR PREPARING SAME | Chong Kun Dang Pharmaceutical Corp. (KR) | 2023-09-06 | — | — | EP | disclosed |
| CN-116685574-A | Acid addition salts of indene derivative prodrugs and methods of making same | 株式会社钟根堂 | 2023-09-01 | — | — | CN | disclosed |
| EP-4198021-A1 | DONEPEZIL ETHER PALMITATE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | Chong Kun Dang Pharmaceutical Corp. (KR) | 2023-06-21 | — | — | EP | disclosed |
| CN-116018140-A | Donepezil Ji Mi palmitate or pharmaceutically acceptable salts thereof | 株式会社钟根堂 | 2023-04-25 | — | — | CN | disclosed |
| WO-2022092813-A1 | ACID ADDITION SALT OF INDENE DERIVATIVE PRODRUG AND METHOD FOR PREPARING SAME | 주식회사 종근당 | 2022-05-05 | — | — | WO | disclosed |
| WO-2022035048-A1 | DONEPEZIL ETHER PALMITATE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | 주식회사 종근당 | 2022-02-17 | — | — | WO | disclosed |
| EP-3934639-A1 | FATTY ACID ANALOGS AND THEIR USE IN THE TREATMENT OF COGNITIVE IMPAIRMENT, BEHAVIORAL CONDITIONS, AND CHRONIC PAIN | Epitracker, Inc. (US) | 2022-01-12 | — | — | EP | disclosed |
| US-20210386710-A1 | FATTY ACID ANALOGS AND THEIR USE IN THE TREATMENT OF COGNITIVE IMPAIRMENT, BEHAVIORAL CONDITIONS, AND CHRONIC PAIN | Epitracker, Inc. | 2021-12-16 | — | — | US | disclosed |
| US-20210386710-A1 | FATTY ACID ANALOGS AND THEIR USE IN THE TREATMENT OF COGNITIVE IMPAIRMENT, BEHAVIORAL CONDITIONS, AND CHRONIC PAIN | Epitracker, Inc. | 2021-12-16 | — | — | US | disclosed |
| US-10792266-B2 | Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome | Epitracker, Inc. (US) | 2020-10-06 | — | — | US | disclosed |
| US-10792266-B2 | Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome | Epitracker, Inc. (US) | 2020-10-06 | — | — | US | disclosed |
| US-20190117607-A1 | FATTY ACID ANALOGS AND THEIR USE IN THE TREATMENT OF CONDITIONS RELATED TO METABOLIC SYNDROME | Epitracker, Inc. | 2019-04-25 | — | — | US | disclosed |
| US-20190117607-A1 | FATTY ACID ANALOGS AND THEIR USE IN THE TREATMENT OF CONDITIONS RELATED TO METABOLIC SYNDROME | Epitracker, Inc. | 2019-04-25 | — | — | US | disclosed |
| EP-0844099-A1 | Heat-sensitive recording material | FUJI PHOTO FILM CO., LTD. (JP) | 1998-05-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303491-A1 | DONEPEZIL ETHER PALMITATE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | NAPEPLD, PSEN1, CETP | CES2 198/4885EPHX2 787/4885PAM 2314/4885 |
| US-20190117607-A1 | FATTY ACID ANALOGS AND THEIR USE IN THE TREATMENT OF CONDITIONS RELATED TO METABOLIC SYNDROME | FABP1, FASN, GPR119 | CES2 1954/4885EPHX2 3189/4885PAM 2295/4885 |
| US-20210386710-A1 | FATTY ACID ANALOGS AND THEIR USE IN THE TREATMENT OF COGNITIVE IMPAIRMENT, BEHAVIORAL CONDITIONS, AND CHRONIC PAIN | SCD, FABP7, ELOVL1 | CES2 205/4885EPHX2 1687/4885PAM 1815/4885 |
| US-10792266-B2 | Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome | FABP1, FASN, GPR119 | CES2 1954/4885EPHX2 3189/4885PAM 2295/4885 |
| US-20230399298-A1 | ACID ADDITION SALT OF INDENE DERIVATIVE PRODRUG AND METHOD FOR PREPARING SAME | IDE, NOTUM, PSEN1 | CES2 144/4885EPHX2 446/4885PAM 1759/4885 |
| US-11951088-B2 | Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome | FABP1, FASN, GPR119 | CES2 1954/4885EPHX2 3189/4885PAM 2295/4885 |
| US-20260048037-A1 | FATTY ACID ANALOGS AND THEIR USE IN THE TREATMENT OF COGNITIVE IMPAIRMENT, BEHAVIORAL CONDITIONS, AND CHRONIC PAIN | CNR1, CNR2, FFAR1 | CES2 133/4885EPHX2 1451/4885PAM 2850/4885 |
| US-12440473-B2 | Fatty acid analogs and their use in the treatment of cognitive impairment, behavioral conditions, and chronic pain | SCD, FABP7, ELOVL1 | CES2 205/4885EPHX2 1687/4885PAM 1815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.